Oramed Pharmaceuticals, Inc. (ORMP)
3.27
+0.10
(+3.15%)
USD |
NASDAQ |
Feb 13, 15:26
Oramed Pharmaceuticals Cash from Investing (Quarterly) : 38.84M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lifeward Ltd. | 0.00 |
| Bristol Myers Squibb Co. | -1.458B |
| Instil Bio, Inc. | 8.447M |
| Nektar Therapeutics | -94.87M |
| Innoviva, Inc. | 18.41M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.987M |
| Cash from Financing (Quarterly) | -0.3926M |
| Free Cash Flow | -11.03M |
| Free Cash Flow Per Share (Quarterly) | -0.0465 |
| Free Cash Flow to Equity (Quarterly) | -1.935M |
| Free Cash Flow to Firm (Quarterly) | -1.987M |
| Free Cash Flow Yield | -8.10% |